Government urges pharma sector to anchor global supply chains via quality, innovation

Union Minister J P Nadda urged India's pharmaceutical industry to lead global supply chains with quality and innovation. India is embracing new technologies for disease detection and diagnostics. Initiatives like Biopharma Shakti and PRIP are boosting manufacturing and research. The nation is committed to regulatory excellence and aligning with global standards. A quality-first approach is key to sustained global competitiveness.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/1Zd4mrz
via IFTTT

Read More

India's drug regulator inspected 90% of cough syrup makers, found lapses, official says

India’s pharmaceutical regulator has launched a thorough inspection of cough syrup manufacturers, discovering several discrepancies in their operating procedures. This decisive action follows alarming reports of child deaths linked to these syrups.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/GxY9vwT
via IFTTT

Read More

Biosimilars & innovation are Dr. Reddy’s growth pill: Generics to remain core business, says co-Chairman & MD GV Prasad

Dr Reddy's Laboratories is strategically shifting focus towards biosimilars and innovation. The company is increasing investment in biosimilars, anticipating significant growth within five years. Generics and active pharmaceutical ingredients will continue to be major revenue sources. Dr Reddy's aims to compete in a biologics-led future by investing in research and development.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/vAW1EzD
via IFTTT

Read More

Expects Pen-G production capacity to touch 10k metric tonnes in 12 months: Aurobindo Pharma

Aurobindo Pharma is set to boost Penicillin-G output to over 10,000 metric tonnes annually. Its China manufacturing facility is projected to reach EBITDA break-even this quarter. The company is also advancing its US operations and developing complex generics. These strategic moves aim for sustainable growth and improved profitability.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/sdLF4H2
via IFTTT

Read More

BahiaFarma, Biocon, Bionovis inks MoU in pharma sector

India and Brazil signed multiple Memoranda of Understanding (MoUs) during Brazilian President Lula da Silva's visit. Key agreements include a pact for developing a breast cancer medicine, cooperation in iron ore blending at Gangavaram Port, and R&D in strategic pharmaceutical ingredients. ApexBrasil and FICCI also agreed to boost trade and investment.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/PnhsZ48
via IFTTT

Read More

Quality Care India plans to invest Rs 600 crore to set up healthcare facility in Nagpur

Quality Care India Limited is set to invest Rs 600 crore in a new 350+ bed multi-speciality hospital in Nagpur. The facility, to be developed on Maha-Metro land near Kasturchand Park Metro Station, aims to strengthen healthcare infrastructure in Central India. This project, a public-private partnership, is expected to create over 1,500 jobs and enhance regional healthcare capacity.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/9QZqgoM
via IFTTT

Read More

Novartis exits India arm, ChrysCapital-led group buys 70.68% stake for ₹1,446 crore

Swiss drugmaker Novartis AG is selling its 70.68% stake in its Indian unit for Rs 1,446 crore to a consortium led by ChrysCapital. This divestment aligns with Novartis' strategy to become a pure-play innovative medicines company, while it maintains a significant presence in India through its wholly owned subsidiary.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/0hWX6Y8
via IFTTT

Read More